Blue Oak Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Blue Oak Pharmaceuticals has a total of 23 patents globally, out of which no patents have been granted. Of these 23 patents, more than 86% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Blue Oak Pharmaceuticals.

Blue Oak Pharmaceuticals was founded in 2016. Th Company is dedicated on developing the next generation of treatments for neurological illnesses. The company anticipates that the first-in-class medications will be discovered by combining unique, custom-designed favoured chemo types with proven in vivo systems neurobiology assays and brain circuit imaging.

Do read about some of the most popular patents of Blue Oak Pharmaceuticals which have been covered by us in this article and also you can find Blue Oak Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Blue Oak Pharmaceuticals patent portfolio.

How many patents does Blue Oak Pharmaceuticals have?

Blue Oak Pharmaceuticals has a total of 23 patents globally. These patents belong to 3 unique patent families. Out of 23 patents, 20 patents are active.

How Many Patents did Blue Oak Pharmaceuticals File Every Year?

Blue Oak Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBlue Oak Pharmaceuticals Applications FiledBlue Oak Pharmaceuticals Patents Granted
20232
20223
202018

How many Blue Oak Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Blue Oak Pharmaceuticals Patent Portfolio

How Many Patents did Blue Oak Pharmaceuticals File in Different Countries?

Blue Oak Pharmaceuticals Worldwide Patent Filing

Countries in which Blue Oak Pharmaceuticals Filed Patents

CountryPatent
Australia2
Brazil2
Canada2
China2
Europe2
Hong Kong (S.A.R.)2
India2
Japan2
Korea (South)2
United States Of America2

Where are Research Centers of Blue Oak Pharmaceuticals Patents Located?

The Research Center of Blue Oak Pharmaceuticals is in the United States of America.

What Percentage of Blue Oak Pharmaceuticals US Patent Applications Were Granted?

Blue Oak Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.

Below are the key stats of Blue Oak Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Blue Oak Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Dechert Llp20%

List of Blue Oak Pharmaceuticals Patents

Blue Oak Pharmaceuticals PatentsTitle
US20230109801A1Compounds And Compositions For Treating Cns Disorders
US20230116114A1Compounds And Compositions For Treating Cns Disorders
EP4084795A1Compounds And Compositions For Treating Cns Disorders
EP4084797A1Compounds And Compositions For Treating Cns Disorders
CN114929235ACompounds And Compositions For Treating Cns Disorders
CN114929228ACompounds And Compositions For Treating Cns Disorders
CA3161867A1Compounds And Compositions For Treating Cns Disorders
CA3165217A1Compounds And Compositions For Treating Cns Disorders
AU2020417248A1Compounds And Compositions For Treating Cns Disorders
AU2020416203A1Compounds And Compositions For Treating Cns Disorders
JP2023509700ACompounds And Compositions For Treating Cns Disorders
JP2023509453ACompounds And Compositions For Treating Cns Failure
HK40082254ACompounds And Compositions For Treating Cns Disorders
HK40082232ACompounds And Compositions For Treating Cns Disorders
IN202217034823ACompounds And Compositions For Treating Cns Disorders
IN202217032225ACompounds And Compositions For Treating Cns Disorders
KR1020220123404ACompounds And Compositions For Treating Cns Disorders
KR1020220123406ACompounds And Compositions For Treating Cns Disorders
BR112022010021A2Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders
BR112022010641A2Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders
WO2022204150A1Compounds And Compositions For Treating Cns Disorders
WO2021138314A1Compounds And Compositions For Treating Cns Disorders
WO2021138315A1Compounds And Compositions For Treating Cns Disorders

What are Blue Oak Pharmaceuticals key innovation segments?

What Technologies are Covered by Blue Oak Pharmaceuticals?

The chart below distributes patents filed by Blue Oak Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Blue Oak Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Blue Oak Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Blue Oak Pharmaceuticals?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.